Chieh-I Chen Selected Research

Abatacept (Orencia)

6/2018	Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy.
5/2017	Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis.
1/2017	Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chieh-I Chen Research Topics

Disease

15	Rheumatoid Arthritis 11/2019 - 01/2016
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 02/2020
7	Pain (Aches) 01/2023 - 02/2014
4	Fatigue 01/2023 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
2	Disease Progression 10/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 10/2022
2	Necrosis 01/2019 - 01/2017
2	Infections 01/2019 - 01/2019
2	Chronic Disease (Chronic Diseases) 01/2018 - 01/2016
2	Pneumococcal Infections 07/2015 - 09/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2023
1	Diarrhea 01/2023
1	Constipation 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Chest Pain (Chest Pains) 01/2023
1	Vomiting 01/2023
1	Cough 01/2023
1	Alopecia (Baldness) 01/2023
1	Nausea 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Skin Neoplasms (Skin Cancer) 10/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2019
1	Human Influenza (Influenza) 07/2015
1	Healthcare-Associated Pneumonia 05/2014
1	Overactive Urinary Bladder (Overactive Bladder) 05/2014
1	Complex Regional Pain Syndromes 10/2008

Drug/Important Bio-Agent (IBA)

12	cemiplimabIBA 10/2023 - 02/2020
10	sarilumabIBA 11/2019 - 01/2016
8	Tumor Necrosis Factor InhibitorsIBA 11/2019 - 01/2016
8	Antirheumatic Agents (DMARD)IBA 01/2019 - 01/2016
5	Adalimumab (Humira)FDA Link 01/2019 - 01/2017
4	LigandsIBA 01/2023 - 01/2021
4	PlatinumIBA 01/2023 - 01/2021
4	Methotrexate (Mexate)FDA LinkGeneric 11/2019 - 01/2016
4	ametantrone (HAQ)IBA 01/2019 - 01/2016
3	Abatacept (Orencia)FDA Link 06/2018 - 01/2017
3	tofacitinibIBA 06/2018 - 01/2017
3	tocilizumab (atlizumab)FDA Link 06/2018 - 01/2017
3	golimumab FDA Link 06/2018 - 01/2017
3	Etanercept (Enbrel)FDA Link 06/2018 - 01/2017
3	Infliximab (Remicade)FDA Link 06/2018 - 01/2017
3	Monoclonal AntibodiesIBA 01/2018 - 01/2017
2	pembrolizumabIBA 01/2022 - 11/2021
2	Certolizumab Pegol FDA Link 05/2017 - 01/2017
1	B7-H1 AntigenIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2018
1	Janus Kinase InhibitorsIBA 06/2018
1	Interleukin-6 (Interleukin 6)IBA 06/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 07/2015
1	Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA 09/2014
1	fesoterodine FDA Link 05/2014
1	Vancomycin FDA LinkGeneric 05/2014
1	Linezolid (Zyvox)FDA Link 05/2014
1	Ibandronic Acid (Boniva)FDA Link 10/2008

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
1	Dermatologic Surgical Procedures 11/2023
1	Aftercare (After-Treatment) 01/2016
1	Incontinence Pads 02/2014